What did you think of this email?
1ScanWatch 2 incorporates a clinically evaluated atrial fibrillation (AF) detection algorithm.
2A study from the American Heart Association has shown that twice-weekly use of this approach is at least three times more likely to identify AF than standard diagnostic methods, in at-risk individuals over the age of 65
3According to an internal study, since 2020, ECG acquisitions performed with Withings products capable of recording an electrocardiogram have detected 2,666,193 signs of atrial fibrillation in our users.
ScanWatch 2 features Scan Monitor functionality, and is a regulated healthcare product bearing the CE mark.
4Via Withings Scan Monitor
You have received this email because you have a Withings account.
This is a promotional email. To unsubscribe from similar emails, click here.
To manage your email preferences, please visit our notification center.
Terms and Conditions | Privacy
Withings 2, rue Maurice Hartmann 92130 Issy-Les-Moulineaux FRANCE
|